Application 063206
- Type
- ANDA
- Sponsor
- XGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMPHOTERICIN B | AMPHOTERICIN B | INJECTABLE;INJECTION | 50MG/VIAL | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A063206-001 | AMPHOTERICIN B | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE / INJECTION | RS | 1992-04-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A063206-001 | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE / INJECTION | RS | 1992-04-29 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A063206-001 | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE / INJECTION | RS | 1992-04-29 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A063206-001 | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE / INJECTION | RS | 1992-04-29 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A063206-001 | AMPHOTERICIN B | 50MG/VIAL | INJECTABLE / INJECTION | RS | 1992-04-29 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amphotericin B | AMPHOTERICIN B | XGen Pharmaceuticals DJB, Inc. | a0a54943-9ce4-4f3e-b681-a1a9144c16ce | 2022-01-03 | Boxed warning, Warnings, Adverse reactions | 063206 ANDA063206 39822-1055 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 39822-1055 | Amphotericin B | Amphotericin B | X-GEN Pharmaceuticals, Inc. | ANDA | Current |
| 39822-1055 | Amphotericin B | Amphotericin B | X-GEN Pharmaceuticals, Inc. | ANDA | Current |
| 39822-1055 | Amphotericin B | Amphotericin B | XGen Pharmaceuticals DJB, Inc. | ANDA | Current |